| P no. | 
        Xolair Dose  | 
        Skin test sensitivity  | 
        SSTa  | 
        Allergic Reaction | 
        Number  
            of  
          Injection | 
        Efficacy of  
          Omalizumab | 
       
      
        | 1 | 
        375 mg q. 2 wk  | 
        Grass, tree, mold, mite  | 
        - | 
        Aller rhin conj, AD  | 
        78 | 
        dose 3: AD and NSS improved significantly  | 
       
      
        | 2 | 
        225 mg q. 2 wk  | 
        Grass, mite, cockroach  | 
        + | 
        Aller rhin conj, NP, MD Aller, angioedema and UC  | 
        72 | 
        dose 5: improvement in UC and angioedema attacks and NSS    decreased  | 
       
      
        | 3 | 
        225 mg q. 2 wk  | 
        Grass, wheat, tree, mold, mite, cockroach, dog and cat    epithelium  | 
        - | 
        Aller rhin conj, NP  | 
        63 | 
        dose 3: improvement in NSS  | 
       
      
        | 4 | 
        300 mg q. 2 wk  | 
        Grass, wheat, tree, mold, mite, cockroach, honeybee, dog    and cat epithelium  | 
        - | 
        Aller rhin conj, NP venom aller, bee-sting anaphylaxis and    UC  | 
        68 | 
        dose 1: decrease in NSS, dose 3: improvement in UC, dose    12: no anaphylactic reaction after 48 honey bee-sting.  | 
       
      
        | 5 | 
        300 mg q. 2 wk  | 
        mold, mite, cockroach, tomato, eggplant, strawberry, dog    epithelium  | 
        - | 
        Aller rhin conj, NP, food aller and anaphylaxis (food. induced)  | 
        64 | 
        dose 1: improvement in NSS  
          dose 6: tolerated    food allergy and no food induced UC  | 
       
      
        | 6 | 
        300 mg q. 2 wk  | 
        Grass, tree, mite, shrimp, perch, egg and latex  | 
        + | 
        Aller rhin conj, NP, MD aller, food aller, latex aller,    anaphylaxis (NSAID induced) and AD  | 
        72 | 
        dose 1: NSS decreased  
          dose 5: AD and food allergy improved significantly  
          dose 10: improvement    in UC and angioedema attacks  | 
       
      
        | 7 | 
        300 mg q. 2 wk  | 
        wheat, tree, mite  | 
        - | 
        Aller rhin conj, NP, MD Aller and AD dermatitis  | 
        74 | 
        dose 3: improvement in NSS  
          dose 5: improvement    in UC  | 
       
      
        | 8 | 
        300 mg q. 2 wk  | 
        Grass, tree, mite, kiwi and orange  | 
        - | 
        Aller rhin conj, NP, MD aller, food aller  | 
        76 | 
        dose 3: Improvement in UC attacks, NSS and F aller.  | 
       
      
        | 9 | 
        225 mg q. 2 wk   | 
        Grass, wheat, tree, mold, mite, cockroach, honeybee, dog    and cat epithelium  | 
        - | 
        Aller rhin conj, NP, MD Aller, venom aller and AD  | 
        72 | 
        dose 2: NSS improved  
          dose 4: no    exacerbation in AD  | 
       
      
        | 10 | 
        300mg q. 2 wk  | 
        Grass, mold,  
          mite,  
          cockroach  | 
        - | 
        Aller rhin conj, MD aller, UC  | 
        64 | 
        dose 4: improvement in UC attacks, NSS  | 
       
      
        | 11 | 
        300mg q. 2 wk  | 
        Grass, tree,  
          mite, dog epitelia  | 
        - | 
        Aller rhin conj and AD 
                        | 
        68 | 
        dose 2: NSS improves  
          dose 6: no    exacerbation in AD  | 
       
     
      AD: Atopic Dermatitis; Aller: Allergy; Conj: Conjunctivitis; MD: mMultidrug; NP: Nasal Polyp; NSAID: Non-Steroidal Anti-Inflammatory Drug; NSS: Nasal Symptom Scoring;
    P: Patient; Rhin: Rhinitis; SSTa: Autologous Serum Skin Test; UC: Urticarial
  |